This issue will present the state-of the-art for treatment of advanced prostate cancer. Individual articles will address the latest updates in topics such as imaging, combined androgen blockade, intermittent androgen deprivation, LHRH antagonists, managing side effects of hormonal therapy, resistance to hormonal therapy, radiation therapy, chemotherapy and alternative therapies.